"395 Wild type HCV-NS5A protein and its naturally occurring mutants modulate HBV replication and gene expression ED - Zoulim Fabien", JOURNAL OF HEPATOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 42, 1 April 2005 (2005-04-01), page 145, XP027780860, ISSN: 0168-8278 [retrieved on 2005-04-01] (B1)

ANNE DE MONTE ET AL: "Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge", JOURNAL OF CLINICAL VIROLOGY, vol. 78, 1 May 2016 (2016-05-01), pages 27-30, XP055393838, NL ISSN: 1386-6532, DOI: 10.1016/j.jcv.2016.02.026 (B1)

David Wyles ET AL: "International Medical Press - Advanced Publication", , 1 January 2017 (2017-01-01), XP055393970, Retrieved from the Internet: URL:https://www.intmedpress.com/journals/a vt/abstract.cfm?id=3181&pid=48 [retrieved on 2017-07-26] (B1)

Edward J Gane ET AL: "International Medical Press - Browse Articles", , 1 July 2016 (2016-07-01), XP055393968, Retrieved from the Internet: URL:https://www.intmedpress.com/journals/a vt/abstract.cfm?id=3066&pid=88 [retrieved on 2017-07-26] (B1)

RESAT OZARAS ET AL: "Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe", HEPATOLOGY, vol. 64, no. 5, 24 May 2016 (2016-05-24), pages 1825-1827, XP055394072, ISSN: 0270-9139, DOI: 10.1002/hep.28592 (B1)

H. GUO ET AL: "Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway", JOURNAL OF VIROLOGY., vol. 81, no. 18, 15 September 2007 (2007-09-15), pages 10072-10080, XP055393674, US ISSN: 0022-538X, DOI: 10.1128/JVI.00541-07 (B1)

JEFFREY M. COLLINS ET AL: "Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir: Figure 1.", CLINICAL INFECTIOUS DISEASES, vol. 61, no. 8, 15 October 2015 (2015-10-15), pages 1304-1306, XP055393597, US ISSN: 1058-4838, DOI: 10.1093/cid/civ474 (B1)

JORG PETERSEN ET AL: "Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?", LIVER INTERNATIONAL, vol. 35, 22 January 2015 (2015-01-22), pages 114-120, XP055393936, GB ISSN: 1478-3223, DOI: 10.1111/liv.12720 (B1)

PAN ET AL: "NS5A protein of HCV enhances HBV replication and resistance to interferon response", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 359, no. 1, 2 June 2007 (2007-06-02), pages 70-75, XP022103144, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2007.05.052 (B1)

GABRIELE FABBRI ET AL: "Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature", BMC INFECTIOUS DISEASES, BIOMED CENTRAL LTD, LONDON, UK, vol. 17, no. 1, 1 March 2017 (2017-03-01), pages 1-5, XP021241765, DOI: 10.1186/S12879-017-2287-Y (B1)